14.alpha.,17.alpha.-ethanoestratrienes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

552510, 552530, A61K 3105, C01J 5300

Patent

active

051341360

ABSTRACT:
##STR1## New 14.alpha.,17.alpha.-ethano-estratrienes of general formula (I) wherein R.sup.1 is a hydrogen atom, an alkyl or acyl group with 1 to 12 carbon atoms, R.sup.2 is a hydrogen atom or a methyl group, R.sup.3 is a hydrogen atom or an acyl group with 1 to 12 carbon atoms and (a) is either (II) or (III), where R.sup.4 is an alkyl residue in the .alpha. or .beta. position with 1 to 8 carbon atoms or an .alpha.,.beta.-alkenyl residue which may contain several double bonds or an .alpha.,.beta.-alkinyl residue, both with 2 to 8 carbon atoms, are described. Also described is a process for producing them. These new compounds have a marked oestrogenic activity.

REFERENCES:
patent: 4789671 (1988-12-01), Bull et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

14.alpha.,17.alpha.-ethanoestratrienes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 14.alpha.,17.alpha.-ethanoestratrienes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 14.alpha.,17.alpha.-ethanoestratrienes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1687144

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.